Shots:
- Fangzhou has partnered with Innovent Biologics to combine digital health services with novel therapies in metabolic diseases & weight management
- Collaboration will integrate Fangzhou’s AI-driven H2H healthcare ecosystem with Innovent’s pipeline, incl. Mazdutide, & leverage Fangzhou’s XS Core AI large language model powering 5 AI tools: AI Medication Finder, AI Health Manager, AI Doctor Assistant, AI Academic Assistant & AI-Powered Search
- AI Medication Finder will provide convenient treatment support, while AI Health Manager delivers monitoring, guidance, & education to improve adherence, allowing personalized, 24/7 digital care
Ref: GlobeNewsWire | Image: Fangzhou & Innovent Biologics | Press Release
Related News:- Remedium Bio Joins Forces with Eli Lilly to Advance Gene Therapies for Obesity and Type 2 Diabetes
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
